Tomonori Tayama

The Influence of Formula Concentration on the Absorption of Darbepoetin Alfa after Subcutaneous Administration

T. Akizawa, K. Kawakami, Sakuo Hoshi, 2010 .

First-in-human study of KHK2455, a long-acting, potent and selective indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor, in combination with mogamulizumab (Moga), an anti-CCR4 monoclonal antibody, in patients (pts) with advanced solid tumors.

D. Hong, T. Yap, R. Latek, 2018 .

Safety, Tolerability, and Pharmacokinetics of the Novel Adenosine A2A Antagonist/Inverse Agonist KW‐6356 Following Single and Multiple Oral Administration in Healthy Volunteers

Y. Kagawa, Yoshinori Nagata, M. Hruska, 2023, Clinical pharmacology in drug development.